Ioanna Markaki

14PUBLICATIONS
36CO-AUTHORS
Toxicology (incl. clinical toxicology)Neurology and neuromuscular diseasesClinical nutritionPharmacogenomicsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 29, 2025
Clinical Outcome Assessments in Parkinson's Disease: A Scoping Review of Current Rating Scales and Future Needs.

Evita Papathoma, Panagiota Tsitsi, Nirosen Vijiaratnam

|Sep 24, 2025
High Cerebrospinal DOPA Decarboxylase Level Predicts Cognitive Decline in Parkinson's Disease.

Andrea Sturchio, Wojciech Paslawski, Shervin Khosousi

|Apr 24, 2025
Vital nutrition: enhancing health in advanced Parkinson's disease with device-aided therapies.

Onanong Phokaewvarangkul, Ioanna Markaki, Harmen R Moes

|Mar 17, 2025
NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian Efficacy.

Per Svenningsson, Per Odin, Filip Bergquist

|Dec 03, 2024
Levodopa-entacapone-carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease.

Mezin Öthman, Filip Bergquist, Per Odin

|Sep 06, 2023
Isolation of L1CAM-Extracellular Vesicles Reveals Signs of Insulin Resistance in Parkinson's Disease.

Ioanna Markaki, Wojciech Paslawski, Theodora Ntetsika

Pageof 3